S100A9 and lung adenocarcinoma: S100A9 strongly activates P38 and Rek1/2 kinases and slightly activates JNK kinase phosphorylation in the MAPK pathway in A549 (human alveolar basal epithelial cells) and SPCA-1 cells, thereby promoting the progression and oncogenic ability of SM in lung adenocarcinoma.